The last flu season was bad, as we noted here. One of the worst in history…
It was nothing short of an epidemic.
Last year, Texas reported more than a dozen flu-related deaths.
Parts of Pennsylvania were under the highest level of outbreak category, according to The Patriot-News. The current “red code” designates “widespread” outbreaks of the flu or flu-like illness throughout the state.
As anyone with a respiratory system will tell you, it was no fun…
But as investors holding pharmacy and flu-related, coughing-sniffling remedy stocks will tell you, it’s one of the best parts of the year…
Clorox (NYSE-CLX), for example, has an historical tendency to appreciate every flu season, as do pharmacy-related stocks, like Rite Aid (NYSE-RAD) and CVS Health (NYSE-CVS).
Then, there’s ProPhase Labs. Inc. (NASDAQ-PRPH), the maker of Cold-EEZE products, which has a tendency to move higher in the colder, winter months of the year. While Cold-EEZE is not an official flu medication, consumers buy Cold-EEZE to treat cold or flu-like symptoms.
We have liked and followed the stock for a long time, and recommended PRPH twice in 2011 at $0.87 and $1.00. It moved up to a high of $2.98. That’s a potential profit of +243% and +198% respectively. The 52 week high this year so far is $1.75.
We’re not recommending a buy on any of the mentioned stocks, but these are some stocks that generally tend to move up during the flu and cold seasons.